Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

Clinical trial NCT00634400 · COMPLETED

Trial details

NCT number: NCT00634400
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congestive Heart Failure

Start date: 1999-03-01
Primary completion: 2003-05-01
Enrollment: 6268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.